Clicky

Clene Inc.(CLNN)

Description: Clene Nanomedicine Inc., a biopharmaceutical company, develops technology solutions for drug development. The company develops Clean-Surface Nanosuspension, a technology that produces clean-surface nanocrystal medicines. Its technology also provides a platform for a pipeline of new drug candidates with application across a spectrum of diseases with unmet medical needs. The company focuses on demyelinating disorders and oncology. Clene Nanomedicine Inc. was incorporated in 2012 and is based in Salt Lake City, Utah.


Keywords: Biotechnology Biopharmaceutical Life Sciences Medication Health Sciences Technology Solutions Drug Development Nanomedicine

Home Page: clene.com

CLNN Technical Analysis

6550 South Millrock Drive
Salt Lake City, UT 84121
United States
Phone: 801 676 9695


Officers

Name Title
Mr. Robert Etherington MBA CEO, Pres & Director
Mr. Mark G. Mortenson Co-Founder & Chief Science Officer
Dr. Robert Glanzman M.D. Chief Medical Officer
Mr. Morgan R. Brown CPA, CPA, M.B.A., MBA Chief Financial Officer
Mr. Jerry Miraglia J.D. Gen. Counsel & Corp. Sec.
Mr. Michael T. Hotchkin Chief Devel. Officer
Ms. Mary Anne Mcneil Head of HR
Dr. Tae Heum Jeong D. Mgt. Consultant

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 3.5862
Price-to-Book MRQ: 108.1979
Price-to-Sales TTM: 187.0781
IPO Date: 2020-12-31
Fiscal Year End: December
Full Time Employees: 95
Back to stocks